← back to search

Paul Bessette

Centre Hospitalier Universitaire de Sherbrooke · CA
Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cancer survivorship and care, and Gynecological conditions and treatments.
h-index
28
citations
4,072
works
85
NIH funding
—
primary concept
Medicine
email
paul.bessette@usherbrooke.ca

Recent publications

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial
Journal of Clinical Oncology 2024cited by 52position: middledoi
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
Journal of Clinical Oncology 2022cited by 372position: middledoi
Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial
Gynecologic Oncology 2020cited by 53position: middledoi
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
The Lancet Oncology 2018cited by 301position: middledoi
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)
Gynecologic Oncology 2015cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Floris A. de Jong · Mundipharma (United Kingdom)1 papers (2020–2020)Dominique Berton-Rigaud · Roswell Park Comprehensive Cancer Center1 papers (2020–2020)Anne Dørum · Nordic Society of Gynecologic Oncology1 papers (2020–2020)Amit M. Oza · University Health Network1 papers (2015–2015)Dhiraj Gupta · University of Liverpool1 papers (2020–2020)Joseph Buscema · The US Oncology Network1 papers (2020–2020)Jonathan A. Ledermann · University College London1 papers (2020–2020)Mansoor Raza Mirza · C4 Therapeutics (United States)1 papers (2020–2020)Elsa Kalbacher · Universitair Ziekenhuis Leuven1 papers (2020–2020)B.J. Rimel · University of Louisville1 papers (2020–2020)Richard T. Penson · Harvard University1 papers (2015–2015)Tally Levy · Wolfson Medical Center1 papers (2020–2020)I. Vergote · KU Leuven1 papers (2015–2015)Jørn Herrstedt · Gentofte Hospital1 papers (2020–2020)José Ángel Arranz · Hospital General Universitario Gregorio Marañón1 papers (2015–2015)Romnee Clark · Indiana University – Purdue University Indianapolis1 papers (2015–2015)— · 1 papers (2015–2015)Diane Provencher · Centre Hospitalier de l’Université de Montréal1 papers (2015–2015)Susie Lau · Jewish General Hospital1 papers (2020–2020)R. Wendel Naumann · Wake Forest University1 papers (2015–2015)